S
Symbiont
A financial technology company delivering enterprise blockchain solutions
About Symbiont
Symbiont positions itself as a specialized financial technology firm, focusing on the application of blockchain and smart contract technologies to overhaul capital markets infrastructure. Established in 2013, the company emerged from the merger of MathMoney f(x), founded by Mark Smith, and Counterparty, a project developed by Adam Krellenstein, Robby Dermody, and Evan Wagner. This union brought together expertise in FinTech and pioneering work in blockchain protocols. Mark Smith, a serial entrepreneur with a history of founding and exiting FinTech companies, was motivated by the 2008 financial crisis to seek technologies that could introduce greater transparency and decentralization to the markets. His background in electronic trading systems and capital markets complements the technical acumen of the Counterparty founders, who were early innovators in using the Bitcoin blockchain for more than just currency transactions.
The company's core offering is the Assembly™ platform, an enterprise blockchain solution engineered for financial institutions. Assembly utilizes a proprietary smart contract language called SymPL™ to model and automate complex, multi-party financial workflows. The platform is designed to create a single, unalterable record of transactions, which aims to eliminate manual data reconciliation and enhance operational efficiency. A key architectural feature is its approach to privacy; it employs end-to-end encryption to ensure that only authorized parties can view transaction details, without relying on a central authority for validation. This allows clients to build and operate on a shared infrastructure while maintaining control over their data.
Symbiont's business model is centered on providing its Assembly platform to large financial services firms, enabling them to develop and deploy decentralized applications for various use cases. The company targets institutional clients such as banks, asset managers, and market infrastructure providers. It generates revenue by licensing its platform and working with partners to build solutions for specific verticals, including syndicated loans, private equity, mortgages, and data management. Symbiont has attracted significant strategic investment and partnerships from major industry players. A notable milestone was its Series B funding round in 2019, which raised $20 million and was led by Nasdaq Ventures, with participation from firms like Citi and Galaxy Digital. This funding has been directed towards platform development and expanding deployments. The partnership with Nasdaq also includes the integration of Assembly into the Nasdaq Financial Framework, aiming to offer tokenization and smart contract solutions to a global network of marketplaces. Other key collaborations include projects with Vanguard to digitize currency forwards and streamline index data management, and a pilot with SWIFT to improve corporate actions workflows.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- New York City, United States
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 60.1/100
- Industry
- Fintech
- Sector
- Fintech, Trading, Risk Management, Security, Decentralised Applications, Hard Tech
- Technology
- Blockchain
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCEquity / VC | Jul 2022 | $0 | — | Pelion Venture Partners | — |
| OtherOther financing | Apr 2021 | $0 | — | Communitas Capital | — |
Growth signals
Latest recorded traffic for Symbiont is 200 monthly website visits, down 87.5% over the last three months. Symbiont's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
SenaHill Partners
Kayon Partners
Duncan L. Niederauer- MAMatt Andresen
Series A12 investors entered at this stage
Celeridem Capital Management- MVMedici Ventures
DHVC (Danhua Capital)- ACAtlantic Merchant Capital
Overstock.com- WCWicklow Capital
Fenbushi Capital
Hundsun Technologies
Galaxy Digital LP
NASDAQ Ventures
Citi
Raptor Group
Series B and later1 investor entered at this stage
Pelion Venture Partners
Other known investors8 additional known investors
Communitas Capital- ASAjay S.
Berkeley SkyDeck Accelerator- CLCarey Lai
Conductive Ventures
DHVC
FirstTracks Ventures- ZCZMT Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Symbiont on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Symbiont’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







